Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-14 Arbuckle Stuart A EVP, COO Sale −2,003 $299.13 $599K 77,739
2023-02-14 Arbuckle Stuart A EVP, COO Sale −1,734 $300.09 $520K 76,005
2023-02-14 Arbuckle Stuart A EVP, COO Sale −400 $300.89 $120K 75,605
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −800 $295.79 $237K 53,596
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −842 $296.85 $250K 52,754
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −395 $297.97 $118K 52,359
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −2,165 $299.08 $648K 50,194
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −1,888 $300.11 $567K 48,306
2023-02-14 ALTSHULER DAVID EVP, Global Research and CSO Sale −308 $301.02 $93K 47,998
2023-02-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −4,992 $298.26 $1.5M 65,191
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes −2,995 $298.26 $893K 66,040
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −2 $295.84 $592 66,038
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −78 $298.11 $23K 65,960
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −120 $298.98 $36K 65,840
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −64 $299.88 $19K 65,776
2023-02-13 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −11 $300.79 $3K 65,765
2023-02-13 Sanna Bastiano EVP, Cell & Genetic Therapies Shares withheld for taxes −4,340 $298.26 $1.3M 62,028
2023-02-13 Sanna Bastiano EVP, Cell & Genetic Therapies Sale −113 $300.39 $34K 61,915
2023-02-13 Sachdev Amit EVP, Chief Patient Officer Shares withheld for taxes −4,657 $298.26 $1.4M 72,484
2023-02-13 LEIDEN JEFFREY M Executive Chairman Shares withheld for taxes −13,344 $298.26 $4.0M 62,079

Page 36 of 40 · 781 trades